Background and Discovery

Griseofulvin was first isolated in 1939 from the mold Penicillium griseofulvum by Oxford and colleagues. It was subsequently identified as a potent antifungal agent and introduced into clinical use in the late 1950s, becoming one of the first orally active antifungal drugs available to clinicians. Its unique spiro-heterocyclic structure distinguishes it from other antifungal drug classes such as azoles and polyenes.

The compound belongs to the benzofuran family of natural products and is produced biosynthetically via a polyketide pathway. Its discovery predates the widespread availability of synthetic antifungals and represents a landmark in natural product pharmacology. Today, griseofulvin also serves as an important research tool in cell biology due to its selective activity on eukaryotic microtubules.

Mechanism of Action

Griseofulvin exerts its antifungal effect primarily by binding to polymerized tubulin and inhibiting microtubule assembly during fungal cell mitosis. By disrupting the mitotic spindle, it arrests dividing fungal cells and prevents normal nuclear segregation, ultimately leading to cell death or growth arrest in susceptible organisms.

At the molecular level, griseofulvin interacts with the colchicine-binding site on β-tubulin, though its precise binding geometry differs from that of colchicine. This interaction stabilizes an intermediate state of tubulin polymerization that is non-functional for mitotic spindle formation. Because mammalian and fungal tubulin differ in their sensitivity to griseofulvin, the drug exhibits selective toxicity toward dermatophytes at therapeutically relevant concentrations.

In addition to its antifungal properties, this mechanism has made griseofulvin a useful research reagent for studying microtubule dynamics, mitotic arrest, and cell cycle progression in both fungal and mammalian cell culture systems.

Research and Laboratory Applications

Beyond its clinical role, griseofulvin is widely employed as a biochemical tool in research laboratories. Its primary research applications include:

• Cell cycle studies: Griseofulvin induces mitotic arrest in mammalian cell lines at the G2/M boundary, enabling synchronized cell population experiments and investigation of spindle assembly checkpoint pathways.
• Microtubule biology: As a microtubule-destabilizing agent with a distinct binding site compared to Vinca alkaloids and taxanes, griseofulvin provides an alternative pharmacological probe for dissecting microtubule dynamics.
• Cancer biology: Emerging research has explored griseofulvin's ability to induce multipolar spindle formation in cancer cells, generating interest in its potential as an anti-proliferative scaffold.
• Antifungal susceptibility testing: Griseofulvin serves as a reference compound in minimum inhibitory concentration (MIC) assays for dermatophytes in mycology research.

When preparing griseofulvin solutions for in vitro experiments, researchers typically dissolve the compound in DMSO to prepare a concentrated stock (e.g., 10–50 mM), followed by dilution into aqueous culture media. Final DMSO concentrations should be kept below 0.1% to avoid solvent cytotoxicity artifacts.

Handling, Storage, and Safety Considerations

Griseofulvin supplied as a research reagent should be handled in accordance with standard laboratory safety practices. Key considerations include:

• Storage: Store at room temperature (15–25 °C) in a tightly sealed container, protected from light and moisture. Check the product-specific certificate of analysis for confirmed purity and storage recommendations.
• Solubility: Griseofulvin has poor aqueous solubility. DMSO and ethanol are the preferred solvents for stock solution preparation. Sonication or gentle warming may aid dissolution.
• Personal protective equipment: Use appropriate PPE including gloves, lab coat, and eye protection when handling the dry powder, as fine particulates may cause irritation.
• Disposal: Dispose of griseofulvin and its solutions in accordance with institutional guidelines for chemical waste and applicable local regulations.

Researchers should consult the Safety Data Sheet (SDS) provided with the product prior to use. Griseofulvin has been classified as a potential carcinogen in animal studies; minimize unnecessary exposure and avoid inhalation of dust.